NASDAQ:KPTI   Karyopharm Therapeutics Inc.
Upcoming data early june, expecting a retest of highs if not higher.
Comment:
bullish

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.